Chicago, IL, United States of America

Guy Adami

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Other. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guy Adami. Retrieved from https://idiyas.com/inventor/guy-adami

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 27(Granted Patents)


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Guy Adami: Innovator in Antibody Research

Introduction

Guy Adami is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific proteins involved in cellular processes.

Latest Patents

Guy Adami holds a patent for "Antibodies to senescent cell-derived inhibitors of DNA synthesis." This patent includes the development of polyclonal and monoclonal antibodies that specifically bind to the senescent cell-derived inhibitor protein (SDI-1). The patent also discloses cell lines that produce such monoclonal antibodies and outlines their potential applications.

Career Highlights

Throughout his career, Guy has focused on advancing the understanding of cellular aging and its implications for health. His work has the potential to impact various therapeutic areas, including age-related diseases.

Collaborations

Guy Adami has collaborated with notable colleagues, including James R. Smith and Asao Noda. These partnerships have contributed to the advancement of research in the field of antibody development.

Conclusion

Guy Adami's innovative work in antibody research exemplifies the importance of scientific inquiry in addressing complex biological challenges. His contributions continue to pave the way for future advancements in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…